LUMOSA THERAPEUTICS CO (ROCO:6535) Days Sales Outstanding : 169.65 (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is LUMOSA THERAPEUTICS CO Days Sales Outstanding?

LUMOSA THERAPEUTICS CO's average Accounts Receivable for the three months ended in Mar. 2024 was NT$8.30 Mil. LUMOSA THERAPEUTICS CO's Revenue for the three months ended in Mar. 2024 was NT$4.46 Mil. Hence, LUMOSA THERAPEUTICS CO's Days Sales Outstanding for the three months ended in Mar. 2024 was 169.65.

The historical rank and industry rank for LUMOSA THERAPEUTICS CO's Days Sales Outstanding or its related term are showing as below:

ROCO:6535' s Days Sales Outstanding Range Over the Past 10 Years
Min: 6.21 Med: 162.28 Max: 2553.17
Current: 74.52

During the past 12 years, LUMOSA THERAPEUTICS CO's highest Days Sales Outstanding was 2553.17. The lowest was 6.21. And the median was 162.28.

ROCO:6535's Days Sales Outstanding is ranked worse than
51.91% of 890 companies
in the Biotechnology industry
Industry Median: 72.665 vs ROCO:6535: 74.52

LUMOSA THERAPEUTICS CO's Days Sales Outstanding increased from Mar. 2023 (125.25) to Mar. 2024 (169.65).

LUMOSA THERAPEUTICS CO Days Sales Outstanding Historical Data

The historical data trend for LUMOSA THERAPEUTICS CO's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LUMOSA THERAPEUTICS CO Days Sales Outstanding Chart

LUMOSA THERAPEUTICS CO Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

336.35

2,553.17

247.33

162.28

83.37

LUMOSA THERAPEUTICS CO Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															125.25	83.29	84.21	59.28	169.65

Competitive Comparison of LUMOSA THERAPEUTICS CO's Days Sales Outstanding

For the Biotechnology subindustry, LUMOSA THERAPEUTICS CO's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LUMOSA THERAPEUTICS CO's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LUMOSA THERAPEUTICS CO's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where LUMOSA THERAPEUTICS CO's Days Sales Outstanding falls into.

LUMOSA THERAPEUTICS CO Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

LUMOSA THERAPEUTICS CO's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (13.998	+	12.003)	/	2 )	/	56.916	*	365
=	13.0005					/	56.916	*	365
=	83.37

LUMOSA THERAPEUTICS CO's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (12.003	+	4.592)	/	2 )	/	4.463	*	365 / 4
=	8.2975					/	4.463	*	365 / 4
=	169.65

LUMOSA THERAPEUTICS CO (ROCO:6535) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

LUMOSA THERAPEUTICS CO Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of LUMOSA THERAPEUTICS CO's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

LUMOSA THERAPEUTICS CO (ROCO:6535) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LUMOSA THERAPEUTICS CO LTD (ROCO:6535) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Yuanyuan Street, 4th Floor, No. 3-2, Nangang District, Taipei, TWN, 11503

Website

https://www.lumosa.com.tw

LUMOSA THERAPEUTICS CO LTD develops new drugs. The company is engaged in the development of drugs for unmet medical needs in the fields of CNS, oncology, and inflammatory diseases. Geographically, it derives a majority of its revenue from Asia and also has a presence in Taiwan and America. Its product portfolio includes LT - 1001 and LT - 3001 for Analgesic Injection and Novel Small Molecules for the Treatment of Acute Ischemic Stroke.

LUMOSA THERAPEUTICS CO (ROCO:6535) Headlines

No Headlines